What Does it Take to Bring a Nicotine Pouch Product to Market?
No time to watch the entire recording? Bonnie Coffa summarizes the key insights from the roundtable discussion here.
Contact our team with questions about laboratory testing to support your nicotine pouch program.
Specialists in Nicotine Pouch Chemistry & Toxicology
Fit-for-purpose methods & relevant tox endpoints for pouch matrices.
Sector-Leading Analytical Techniques
Defensible data that
withstand review.
FDA-Recognized Nicotine Pouch Experts
Packages aligned with
FDA review expectations.
Track Record of MGO Support
Demonstrated experience helping clients achieve MGOs.
Meet Our Panelists
Pete Gibbons, PhD
Director of Business Development, Labstat
Pete Gibbons leads business development for Labstat International’s Reduced-Risk Products (RRP) sector, where he focuses on expanding advanced analytical testing services for nicotine products. With a background as Head of Reduced-Risk Product Analysis at Element Life Sciences EMEAA, Peter brings deep expertise in analytical science, product evaluation, and market development. He works closely with manufacturers and regulators to support science-driven, defensible approaches to nicotine product safety and performance.
Beth G. Oliva
Partner, Fox Rothschild
Beth Oliva is a Partner at Fox Rothschild LLP, who has advised tobacco and nicotine clients for nearly 20 years. Her practice focuses on advising nicotine and tobacco product manufacturers on FDA compliance, premarket review, and post-marketing requirements. She works closely with clients from product development through PMTA submission, drawing on deep experience before FDA and state agencies, as well as extensive collaboration with scientific and medical experts to support defensible regulatory strategies. She serves on the Board of Directors of the Food and Drug Law Institute (FDLI) and the Nicotine Resource Consortium (NRC).
Stanley E. Gilliland III, PhD
Senior Vice President of Chemistry and Material Science, Sapphire Sciences
As Senior VP of Chemistry and Material Science as Sapphire Sciences, Stanley E. Gilliland III leads regulatory science and strategic consulting services for FDA-regulated tobacco and nicotine products. He has worked extensively in the FDA-regulated nicotine and tobacco product space since 2018, supporting client companies from early product development through all phases of the PMTA process, with particular depth in nicotine pouch submissions.
Peter Joza
Vice President of Scientific Research and Commercialization, Labstat
Pete Joza brings more than three decades of scientific leadership in analytical and production laboratory environments, with deep expertise in analytical methods, instrumentation, and quality systems. He has led laboratory teams in method development, data integrity, and Total Quality Management, and is highly experienced in communicating complex scientific information in both regulatory and commercial settings.
Bonnie Coffa, PhD, DABT
Scientific Director of Toxicology, Labstat & ToxPharm LLC
Bonnie Coffa is a board-certified toxicologist with more than a decade of experience supporting nicotine and cannabis products across regulatory science, in vitro toxicology, and risk assessment. She works with manufacturers on toxicological evaluations, literature reviews, and FDA regulatory applications, delivering clear, science-based insights to support defensible product submissions.
About Certified Group
Certified Group partners with customers to deliver innovative scientific solutions and expertise – So The World Can Trust In What It Consumes™. As a leading provider of laboratory testing, regulatory consulting, and certification & audit services, Certified Group includes Food Safety Net Services (FSNS), FSNS Certification & Audit, Certified Laboratories, EAS Consulting Group, and Labstat International Inc. Certified Group provides analytical testing and regulatory guidance services in the food & beverage, dietary supplements & NHP, cosmetics, OTC, personal care, tobacco, nicotine, cannabis, and hemp industries.